Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2024-06762 | Registry Identifier | NCI Clinical Trial Reporting Program (CTRP) | |
| R01CA277782 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.
PRIMARY OBJECTIVE:
I. Validate a previously developed step-count model for predicting all-cause acute care (pooled across all devices).
SECONDARY OBJECTIVES:
I. Validate a previously developed model for predicting each ED visits or hospitalizations during external beam RT using continuous step counts before, during, and after treatment.
II. Validate the previously developed step-count model for predicting all-cause acute care for each of the two different device platforms.
III. Validate concordance of step counts across each of the device's platforms in the Apple group.
IV. Validate the previously developed SHIELD-RT Electronic health record (EHR)-based model for predicting unplanned acute care (ED visit or hospitalization).
EXPLORATORY OBJECTIVES:
I. Refinement of the pre-existing models(step count and SHIELD-RT). II. Evaluate association between wearables collected parameters, EHR-based variables, and acute care events.
III. Develop and validate a multi-modal predictive model for predicting acute care.
OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Observational Group I: Fitbit only | Participants receive Fitbit device while undergoing non-interventional, standard of care, radiation therapy. |
| |
| Observational Group II: Fitbit + Apple HealthKit | Participants receive Fitbit device and will utilize personal Apple HealthKit-based devices (iPhone, Apple Watch, etc.) to concurrently contribute Apple HealthKit-based data while undergoing non-interventional, standard of care, radiation therapy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fitbit | Device | Participants will wear Fitbit device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Area under the receiver operating characteristic curve (AUC-ROC) of the step count model | The AUC-ROC of the step count model will measure the performance of a classification model by plotting the rate of true positives against false positives, and the score ranges from 0 - 1. The higher the AUC, the better the model's performance at distinguishing between the positive and negative classes. The AUC-ROC will be reported including both estimates and confidence intervals. All models will be reported per up-to-date guidelines, such as Minimum Information about Clinical Artificial Intelligence Modeling (MI-CLAIM) and Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD). The performance metrics will only be calculated with respect to first acute care event. | Up to 3 years |
| Calculation of a Brier Score | The Brier Score is a strictly proper score function or strictly proper scoring rule that measures the accuracy of probabilistic predictions. A Brier Score can take on any value between 0 and 1, with 0 being the best score achievable and 1 being the worst score achievable. The lower the Brier Score, the more accurate the prediction(s). The score will be reported including both estimates and confidence intervals. All models will be reported per up-to-date guidelines, such as MI-CLAIM and TRIPOD. The performance metrics will only be calculated with respect to first acute care event. | Up to 3 years |
| Calculation of Log-Loss Score | Logarithmic loss indicates how close a prediction probability comes to the actual/corresponding true value. The Log-Loss Score can take on any value between 0 and 1. The more the predicted probability diverges from the actual value, the higher is the log-loss value. The log-loss value will be reported including both estimates and confidence intervals. All models will be reported per up-to-date guidelines, such as MI-CLAIM and TRIPOD. The performance metrics will only be calculated with respect to first acute care event. | Up to 3 years |
| Area Under the Precision-Recall Curves (AUCPR) |
| Measure | Description | Time Frame |
|---|---|---|
| AUC-ROC for composite acute care | The AUC-ROC will be used to validate a previously developed model in the primary endpoint for predicting each ED visits or hospitalizations during external beam RT using continuous step counts before, during, and after treatment. | Up to 3 years |
| Area under the receiver operating characteristic curve (AUC-ROC) for all cause acute care by group |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult patients undergoing non-interventional, standard of care, radiotherapy (RT) at UCSF Department of Radiation Oncology
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Imani Dunn | Contact | 877-827-3222 | Imani.Dunn@ucsf.edu |
| Name | Affiliation | Role |
|---|---|---|
| Julian Hong, MD, MS | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California, San Francisco | Recruiting | San Francisco | California | 94143 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019337 | Hematologic Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Apple HealthKit-based devices | Device | Participants will wear personal device and share data with study team. |
|
|
The area under the precision-recall curve (AUCPR) is a single number summary of the information in the precision-recall (PR) curve. It represents the tradeoff between precision and recall for different thresholds, where high AUCPR indicates both high recall and high precision. The AUCPR will be reported including both estimates and confidence intervals. All models will be reported per up-to-date guidelines, such as MI-CLAIM and TRIPOD. The performance metrics will only be calculated with respect to first acute care event. |
| Up to 3 years |
The AUC-ROC will be used to validate the previously developed step-count model in the primary endpoint for predicting all-cause acute care for each of the two different device platforms. |
| Up to 3 years |
| Mean squared error (MSE) | The MSE will be used to validate concordance of step counts across each of the device's platforms in the Apple group. Mean Squared Error (MSE) is a fundamental concept in statistics and machine learning in assessing the accuracy of the predictive models which measures the average squared difference between predicted values and the actual values in the dataset. | Up to 3 years |
| Area under the receiver operating characteristic curve (AUC-ROC) for the composite acute care endpoint.. | Validate the previously developed SHIELD-RT EHR-based model for predicting unplanned acute care (ED visit or hospitalization) to discover additional variables which may be predictors not previously included. | Up to 3 years |